These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7147362)

  • 21. Doxorubicin cardiotoxicity in children.
    Biancaniello T; Meyer RA; Wong KY; Sager C; Kaplan S
    J Pediatr; 1980 Jul; 97(1):45-50. PubMed ID: 7381647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Digoxin therapy in patients with long-term digitalis therapy. Comparison of the digoxin blood level after oral administration of digoxin and beta-methyldigoxin].
    Hennersdorf G; Leithäuser H
    Fortschr Med; 1980 Mar; 98(11):(410-2). PubMed ID: 7372228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical importance of determining the digoxin level in the serum in long-term beta-methyldigoxin treatment].
    Todorova R; Baltadzhieva D; Staneva D
    Vutr Boles; 1987; 26(6):26-9. PubMed ID: 3439149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of beta-methyldigoxin on the embryonal and fetal chicken heart].
    Rickenbacher J; Schläpfer R
    Schweiz Med Wochenschr; 1985 May; 115(18):625-9. PubMed ID: 4001908
    [No Abstract]   [Full Text] [Related]  

  • 25. The left ventricular systolic function after digoxin administration in patients with chronic renal failure.
    Trznadel K; Luciak M; Wyszogrodzka M
    Clin Nephrol; 1980 May; 13(5):231-4. PubMed ID: 7398145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metildigoxin (beta-methyldigoxin) on congestive heart failure as evaluated by multiclinical double blind study.
    Kimura E; Sakuma A
    Jpn Heart J; 1980 Jan; 21(1):47-57. PubMed ID: 6988622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.
    Hausdorf G; Morf G; Beron G; Erttmann R; Winkler K; Landbeck G; Keck EW
    Br Heart J; 1988 Oct; 60(4):309-15. PubMed ID: 3190959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.
    Friedman MA; Bozdech MJ; Billingham ME; Rider AK
    JAMA; 1978 Oct; 240(15):1603-6. PubMed ID: 691145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects and pharmacokinetics of beta-methyldigoxin.
    Cristodorescu R; Gavrilescu S; Deutsch G; Popoviciu V; Comşulea L; Luca C
    Med Interne; 1981; 19(3):265-75. PubMed ID: 7302506
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II study of 4'epi-doxorubicin.
    Ferrazzi E; Nicoletto O; Vinante O; Pagnin P; Maraglino G; Ganzina F; Fiorentino MV
    Tumori; 1982 Oct; 68(5):431-5. PubMed ID: 6960591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous-infusion schedules.
    Berrak SG; Ewer MS; Jaffe N; Pearson P; Ried H; Zietz HA; Benjamin RS
    Oncol Rep; 2001; 8(3):611-4. PubMed ID: 11295089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs.
    Kuhlmann J; Rietbrock N; Schnieders B
    J Cardiovasc Pharmacol; 1979; 1(2):219-34. PubMed ID: 94391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A correlation between digoxin plasma concentrations and systolic time intervals in hospitalized congestive heart failure patients.
    Vemuri S; Barr WH; Propert DB
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):388-93. PubMed ID: 1446955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of the gastric acidity on the digoxinemia. Comparison between digoxin and beta-methyldigoxin (author's transl)].
    Pasotti C; Rossi R; Zanetta R
    G Ital Cardiol; 1980; 10(12):1669-74. PubMed ID: 7250591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin concentration in cerebrospinal fluid-a study carried out after 9 days of treatment of beta-methyldigoxin or beta-acetyldigoxin.
    Bonelli J; Rameis H; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):93-5. PubMed ID: 7228456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxication.
    Kuhlmann J
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):543-8. PubMed ID: 6511130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radioimmunological determination of digitalis in the blood during treatment with beta-methyldigoxin in patients with different degrees of renal function].
    Gobbi A; Tabacchi GC; Giangrande A; Crespi G
    Minerva Cardioangiol; 1980 Jun; 28(6):445-51. PubMed ID: 7242930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.